Sironax announced that the U.S.

Lysoway Therapeutics announced that the first par

Function announced that it has acquired SuppCo, a

Coya Therapeutics announced that the U.S.

MetaVia Inc.

Suzhou-based Ribo has entered a strategic collabo

Longevity.

The UAE capital wants startups, investors and sc

FDA signals Clene’s ALS therapy may qualify fo

Wellthspan Advisory’s Nadine Esposito explains

New Blue Peptide serum taps into growing demand

LifespanningRx and RegenTherapy announced a strat

Mbx Biosciences provided an update on its obesity

Vasa Therapeutics announced 11 May 2026 that an a

PulseSight presented Phase 1 data for PST-611 at

Fractyl Health received Clinical Trial Applicatio

Brain health experts explain why cognitive decli

New Longevity Show blog examines how hospital le

Lab-grown universal red blood cells survive in v

ROKIT Healthcare shares two-year skin cancer rec

Abu Dhabi’s Department of Health invited global

Function Health emphasized its positioning as a d

Annovis Bio Inc.

Eisai Co., Ltd. and Biogen Inc.

Longeveron Inc. held a Type C meeting with the U.

Alterity Therapeutics will deliver three presenta

Rznomics announced that the U.S.

Ahead of The Longevity Show, Steve Horvath expla

Neuraly-backed study explores whether a long-act

Voyager’s latest preclinical results suggest b

AI imaging expanded to routine scans, turning ev

Global teams gain funding and data access to ide

Diathrive Health and AliveCor’s KardiaComplete

Neuvasq presented preclinical data at the ARVO 20

AlzeCure Pharma published a scientific article in

Biograph introduced a next-generation Executive P

The latest analyses suggest consistency may be v

ParcelBio’s platform aims to extend mRNA expre

A landmark conference hosted by GlycanAge aims t

Beacon Biosignals turns nights into neural insig

Elevant explores NAD⁺ biology and Seneque-back

Restore Hyper Wellness has declared May its first

Tune Therapeutics will present late-breaking Phas

ROKIT Healthcare presented clinical outcomes of a

Neuraly, Inc.

Partners can offer clinician-guided peptide ther

The company stops its Phase 2 study of nivisneba

Chi Longevity reflects growing convergence of pr

Allen Law shares his blueprint for closing the h

BioAge will host an R&D Day webcast on 8 May 2026